YUKIN THERAPEUTICS
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a protein involved in the development of several types of cancer: the NIK protein (NF-κB inducing kinase). Yukin Therapeutics led studies that demonstrated proof of concept in animal models and is now actively seeking to identify a first drug candidate to launch a clinical trial in oncology.
YUKIN THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2018-01-01
Address:
Biot, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.yukintx.com
Total Employee:
1+
Status:
Active
Total Funding:
3.3 M EUR
Technology used in webpage:
Squarespace Hosted
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
Eidos Therapeutics
Eidos Therapeutics is a clinical-stage biotech company developing novel, genetically targeted therapies to improve the lives of patients.
GoLiver Therapeutics
GoLiver Therapeutics is specialized in the development of Innovative Therapy Medicines to meet an unmet urgent medical.
Noviga Research
Noviga Research is focused on the development of small molecules for the new, more effective treatment of cancer.
Galectin Therapeutics
Galectin Therapeutics uses galectin science and drug development to create new therapies for fibrotic diseases and cancer.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Upfront Chromatography
Upfront Chromatography is specialized in the development of customized protein separation processes.
Current Employees Featured
Founder
Investors List
Medicxi
Medicxi investment in Venture Round - Yukin Therapeutics
AdBio partners
AdBio partners investment in Venture Round - Yukin Therapeutics
Official Site Inspections
http://www.yukintx.com
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Yukin Therapeutics"
Yukin Therapeutics - Crunchbase Company Profile & Funding
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a …See details»
Yukin Therapeutics SAS - Life-Sciences-Europe.com
Jun 29, 2018 https://www.yukintx.com Yukin Therapeutics is a French biotechnology company founded in 2018 in Nice, France by Advent France Biotechnology and the SATT Sud-Est. The …See details»
Yukin Therapeutics - PitchBook
Yukin Therapeutics General Information Description. Developer of a proprietary therapeutic molecule designed to offer therapeutic molecules for cancer …See details»
YUKIN THERAPEUTICS Overview | SignalHire Company Profile
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a …See details»
Yukin Therapeutics - EU-Startups
Yukin Therapeutics is a French biotechnology company. The company focuses on the development of new therapeutic molecules, entitled kinase inhibitors, specifically targeting a …See details»
YUKIN THERAPEUTICS | LinkedIn
YUKIN THERAPEUTICS | 334 followers on LinkedIn. | YUKIN THERAPEUTICS is a pharmaceuticals company based in Valbonne, Provence-alpes-côte-d’azur, France.See details»
Yukintx - Company Profile - Tracxn
Yukintx - Limited information available. Raised funding from 2 investors. Yukintx has 100 competitors.See details»
PRESS RELEASE Yukin Therapeutics raises 3.3 million to develop …
PRESS RELEASE Yukin Therapeutics raises €3.3 million to develop new cancer treatments • Yukin Therapeutics develops kinase inhibitors specifically targeting the NIK protein, known for …See details»
YUKIN THERAPEUTICS Staff Directory & Email Format - ContactOut
Explore YUKIN THERAPEUTICS staff directory for direct access to contact details on 8 employees including email format, email address and phone numbers.See details»
Yukintherapeutics
Passer au contenuSee details»
Yukintx - Raised Funding from 2 investors - Tracxn
Yukintx has raised funding from 2 investors. Investors include AdBio partners and Advent France Biotechnology.See details»
NIK kinase inhibitor - life-sciences-europe.com
Life Sciences Business Intelligence Web Portal for European countriesSee details»
Yukin Therapeutics–SEVERAL: investment, 201906 financing round …
Upcoming Events. EUROMAR 2024 Bilbao; J.P. Morgan 43rd Annual Healthcare Conference 2025 San Francisco; BayOConnect 2024 München (Munich) – Forum for Biotech & LifeScienceSee details»
Jean-Baptiste Bouin - Project Manager - ZoomInfo
View Jean-Baptiste Bouin's business profile as Project Manager . Find contact's direct phone number, email address, work history, and more.See details»
Yukin Therapeutics–Medicxi Ventures: investment, 201906 …
Upcoming Events. Asia Bio Partnering Forum 2024 Singapore; ECCMID 2024 Barcelona; LSX World Congress 2024 London; J.P. Morgan 43rd Annual Healthcare Conference 2025 San …See details»
Yukintx : Site en construction
Yukintx.com is 6 years 3 months old. It is a domain having com extension. This website is estimated worth of $ 8.95 and have a daily income of around $ 0.15. As no active threats were …See details»
Yukonstruct
A shared space for Northern changemakers, innovators, and makers Yukonstruct Society is a non-profit organization driven by a vibrant community of makers, entrepreneurs, creators, …See details»
Organization XVX - YouTube
Welcome to Organization XVX! We are a team of animators, spriters, artists, and voice actors with one common goal! That goal is to bring entertainment to our community, improve our skills, …See details»
Yukin Therapeutics–Medicxi Ventures: investment, 201906 …
Upcoming Events. BIO Investor Forum 2023 San Francisco; Entrepreneurship Summit 2023 Berlin; ESGCT 2023 Brussels; HealthTech Innovation Days 2023 (HTID 2023) ParisSee details»
Yukin Therapeutics SAS. (6/4/19). "Press Release: Yukin …
Life Sciences Business Intelligence Web Portal for European countriesSee details»